0001567619-18-001512.txt : 20180820 0001567619-18-001512.hdr.sgml : 20180820 20180820214602 ACCESSION NUMBER: 0001567619-18-001512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180816 FILED AS OF DATE: 20180820 DATE AS OF CHANGE: 20180820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOYLE JOHN C CENTRAL INDEX KEY: 0001278454 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36330 FILM NUMBER: 181029416 MAIL ADDRESS: STREET 1: 2 CORPORATE DR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLIGHT HEALTH, INC. CENTRAL INDEX KEY: 0001433714 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 261989091 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 SPEAR STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-671-4683 MAIL ADDRESS: STREET 1: 150 SPEAR STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: VENTANA HEALTH SERVICES, INC. DATE OF NAME CHANGE: 20090831 FORMER COMPANY: FORMER CONFORMED NAME: MARIA HEALTH INC DATE OF NAME CHANGE: 20080429 4 1 doc1.xml FORM 4 X0306 4 2018-08-16 0 0001433714 CASTLIGHT HEALTH, INC. CSLT 0001278454 DOYLE JOHN C C/O CASTLIGHT HEALTH, INC. 150 SPEAR ST., SUITE 400 SAN FRANCISCO CA 94105 1 1 0 0 Chief Executive Officer Class B Common Stock 2018-08-16 4 M 0 7813 0 A 207876 D Class B Common Stock 2018-08-16 4 M 0 18750 0 A 226626 D Class B Common Stock 2018-08-16 4 M 0 23750 0 A 250376 D Class B Common Stock 2018-08-17 4 S 0 19024 2.6986 D 231352 D Restricted Stock Units 0 2018-08-16 4 M 0 7813 0 D Class B Common Stock 7813 46875 D Restricted Stock Units 0 2018-08-16 4 M 0 18750 0 D Class B Common Stock 18750 150000 D Restricted Stock Units 0 2018-08-16 4 M 0 23750 0 D Class B Common Stock 23750 332500 D Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4. Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4. Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. Represents the weighted average sales price per share. The shares sold at prices ranging from $2.675 to $2.825 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. /s/ Jennifer Chaloemtiarana, by power of attorney 2018-08-20